Choroidal Neovascularisation
3 clinical trials · Condition
◉ Watch Choroidal Neovascularisation
| Record | Firm | Date |
|---|---|---|
| Resveratrol for Exudative Age-Related Macular Degeneration (NCT02625376) | Poitiers University Hospital | 2015-08-06 |
| Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen (NCT01037348) | Novartis | 2010-01-01 |
| Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy (NCT00344617) | Singapore National Eye Centre | 2006-06-01 |
Track Choroidal Neovascularisation automatically
Every clearance here is in the API, with alerts when new ones post.